• General Dermatology
  • Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Article

CTCL Mystery

San Francisco - Molecular profiling is an important piece of the puzzle in identifying cutaneous T cell lymphoma (CTCL), Werner Kempf, M.D., said at the annual meeting of the American Academy of Dermatology.

Related Videos
E. James Song is featured in this video series.
E. James Song is featured in this video series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
1 KOL is featured in this series.
2 KOLs are featured in this series.
Related Content
Derm In The News: September 29-October 5
October 5th 2024

Derm In The News: September 29-October 5

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

GPP Therapies: Comparing Efficacy and Safety of Secukinumab and Ustekinumab
October 4th 2024

GPP Therapies: Comparing Efficacy and Safety of Secukinumab and Ustekinumab

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Significant Proportion of Patients With AD Maintain Stable EASI With Tralokinumab Treatment
October 4th 2024

Significant Proportion of Patients With AD Maintain Stable EASI With Tralokinumab Treatment

9 Months of Treatment With Tralokinumab Results in Improved QoL, Itch, and Sleep
October 4th 2024

9 Months of Treatment With Tralokinumab Results in Improved QoL, Itch, and Sleep

© 2024 MJH Life Sciences

All rights reserved.